Treprostinil (TYVASO) 0.6 MG/ML inhalation soln refill kit
Ended Awarded Last action
- Contract number
- VA26117F0003
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $116,563
Award facts
- Contract value 100% obligated
- $116,562.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20910, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $1,170 | |
| Supplemental Agreement for work within scope | -$390 | |
| Original award | $115,783 |
About this award
This is a federal delivery order contract awarded by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corporation, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The contract is for the provision of Tyvaso (treprostinil) 0.6 mg/mL inhalation solution refill kits, with a ceiling value of $116,562.99. This delivery order is placed against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs and has a firm-fixed price structure. The contract supports the VA's mission of providing specialized medical treatments to veterans, with the performance period running from October 1, 2016 to September 30, 2017. United Therapeutics also holds a $50 million Blanket Purchase Agreement (BPA) and a $198 million FSS contract with the VA, which allow for the procurement of a range of the company's pharmaceutical products, including treatments for pulmonary arterial hypertension and certain types of cancer.
Quick answers
Who was awarded contract VA26117F0003?
VA26117F0003 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 21 (Veterans Health Administration) on October 1, 2016.
How much is contract VA26117F0003 worth?
The government has obligated $116,563 on VA26117F0003.
Is contract VA26117F0003 an order under another contract?
Yes. VA26117F0003 is a delivery order under V797D40275, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA26117F0003 competed?
The extent of competition for VA26117F0003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award